- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.11. | With narcolepsy trial win, Axsome looks to revive former Pfizer antidepressant on the US market | ||
| 27.11. | Most life sciences CEOs expect to grow their head counts over the next 3 years: KPMG survey | ||
| 26.11. | Novartis plots more than 100 layoffs in New Jersey as part of rework to Xolair, cancer combo field sales teams | ||
| 26.11. | Portuguese CDMO Hovione completes factory expansions in US, Ireland | ||
| 26.11. | Shorla gains FDA nod for first oral liquid version of Novartis' Gleevec | ||
| 26.11. | Guardant awarded $293M in false advertising case against fellow cancer test maker Natera | ||
| 26.11. | Fast-growing Adragos snaps up Swiss CDMO Baccinex, significantly expanding fill-finish firepower | ||
| 25.11. | ASH: Incyte's Monjuvi triumphs in follicular lymphoma phase 3, teeing up FDA filing | ||
| 25.11. | India's Lupin recalls more than 600K bottles of blood pressure med over questionable API source | ||
| 25.11. | Bristol Myers Squibb hands pink slips to 195 workers in NJ as cost-cutting effort rolls on | ||
| 25.11. | AstraZeneca's Truqap delivers phase 3 win in prostate cancer subtype after recent breast cancer miss | ||
| 25.11. | A possible ban on DTC pharma ads poses 'biggest threat' of RFK Jr.'s HHS appointment: analyst | ||
| 25.11. | Merck preps filings after blockbuster-in-waiting Winrevair succeeds in severe PAH study | ||
| 25.11. | Look out, Pfizer: BridgeBio scores 'best-case' FDA nod for Attruby in cardiomyopathy | ||
| 23.11. | Trump selects surgeon and author Martin Makary for FDA commissioner post | ||
| 22.11. | After FDA setbacks, Lexicon slashes commercial operations in transition back to clinical-stage outfit | ||
| 22.11. | Calcium+Company enriches comms work with new commercial planning, market access division | ||
| 22.11. | As J&J tries to wrap up US talc litigation, the company now faces threat of class action in UK | ||
| 22.11. | As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact | ||
| 22.11. | Roche's Vabysmo shows potential to treat eye disorder common in Asia | ||
| 22.11. | Fierce Pharma Asia-Big Pharma's China layoffs, CSL's site closure and Kyowa Kirin's oncology deal | ||
| 21.11. | Biopharma status quo 'likely to persist' under Trump 2.0, though changes to IRA, FTC and more could be on the way: analyst | ||
| 21.11. | Novartis, after slimming down, boosts growth projection through the end of the decade | ||
| 21.11. | Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for top FDA job: reports | ||
| 21.11. | Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AstraZeneca and Daiichi's Enhertu |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
